Omalizumab |
Omalizumab Products |
| Add-on omalizumab quells high-risk Asthma. (Experimental Anti-IgE Adjunct Therapy).: An article from: Family Practice News Miriam E. Tucker International Medical News Group The Gale Group International Medical News Group |
Sale Price: $5.95
|
| Anti-IgE Tx cuts asthma exacerbations: Omalizumab.(Clinical Rounds): An article from: Family Practice News Kerri Wachter International Medical News Group International Medical News Group |
Sale Price: $5.95
|
| Omalizumab pretreatment may boost immunotherapy's safety.(Clinical Rounds) : An article from: Family Practice News Bruce Jancin Thomson Gale Thomson Gale |
Sale Price: $5.95
|
| Biologic therapy approved for moderate to severe allergic asthma: omalizumab binds to immunoglobulin E. (Clinical Rounds).: An article from: Pediatric News Elizabeth Mechcatie International Medical News Group The Gale Group International Medical News Group |
Sale Price: $5.95
|
| Asthma rx, omalizumab, tied to late-onset anaphylaxis.(News) : An article from: Family Practice News Patrice Wendling Thomson Gale Thomson Gale |
Sale Price: $5.95
|
| Rush immunotherapy safer with omalizumab pretreatment.(Disease/Disorder overview) : An article from: Internal Medicine News Bruce Jancin Thomson Gale Thomson Gale |
Sale Price: $5.95
|
| Add-on omalizumab quells high-risk asthma. (Clinical Rounds: Experimental anti-IgE therapy).(Brief Article): An article from: Internal Medicine News Miriam E. Tucker International Medical News Group The Gale Group International Medical News Group |
Sale Price: $5.95
|
| Biologic therapy endorsed for asthma indication. (Omalizumab Binds to Immunoglobulin E).: An article from: Internal Medicine News Elizabeth Mechcatie International Medical News Group The Gale Group International Medical News Group |
Sale Price: $5.95
|
| Omalizumab cuts reliance on inhaled steroids. (Allergic Asthma).: An article from: Pediatric News Timothy F. Kirn International Medical News Group The Gale Group International Medical News Group |
Sale Price: $5.95
|
| Treatment of recalcitrant atopic dermatitis with omalizumab.(WASHINGTON WHISPERS) : An article from: Journal of Drugs in Dermatology Frank Victor Thomson Gale Thomson Gale |
Sale Price: $5.95
|
| FDA okays omalizumab for allergic asthma. (Targets Immunoglobulin E).: An article from: Skin & Allergy News Elizabeth Mechcatie International Medical News Group The Gale Group International Medical News Group |
Sale Price: $5.95
|
| Omalizumab Cuts Inhaled Steroid Use in Allergic Asthma.: An article from: Internal Medicine News Betsy Bates International Medical News Group The Gale Group International Medical News Group |
Sale Price: $5.95
|

Not Signed In - 


